Kato Barbara Klyslie, Rego Leticia Souza, Santos Pedro Bizarro Dos, Hojaij Flavio Carneiro
Department of Medicine, Universidade Municipal de São Caetano do Sul (USCS), São Caetano do Sul, SP, Brazil.
Faculty of Medicine, Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.
Int Arch Otorhinolaryngol. 2025 Apr 28;29(2):1-6. doi: 10.1055/s-0044-1789613. eCollection 2025 Apr.
The management of recurrent thyroglossal duct cysts poses persistent challenges. The present review assesses chemical ablations and surgical re-interventions as strategies for recurrence. However, limited comparative studies exist to determine the optimal approach and follow-up outcome. The aim of the current study is to conduct a review gathering evidence from the literature to analyze and synthesize the safest and most effective approaches for treating recurrent thyroglossal duct cysts. The present study aims to comprehensively search electronic databases, including the Latin American and Caribbean Literature in Health Sciences (Literatura Latino-Americana e do Caribe em Ciências da Saúde, LILACS, in Portuguese), the database of the (JAMA), SciVerse Scopus, Virtual Health Library (Biblioteca Virtual em Saúde, BVS, in Portuguese), and PubMed, for articles on recurrent thyroglossal duct cysts. The selected articles include patients with recurrent cysts, cover publications from 2000 to 2022, describe clinical and/or surgical interventions, and ensure the safety and efficacy of the analyzed approach. The present review included 9 studies, involving a cohort of 278 patients. Out of these patients, 143 underwent surgical interventions and 135 underwent chemical ablations (82 using ethanol and 53 with OK-432). Conservative management of recurrent thyroglossal duct cysts is a growing trend, albeit requiring further refinements. This approach presents potential advantages, including decreased recurrence rates, shorter surgical duration, cost-effectiveness, and expedited recovery. Nevertheless, surgical intervention remains the preferred therapeutic choice owing to its established efficacy and widespread familiarity. The projected therapeutic approach shifts for thyroglossal duct cysts as conservative treatment gains substantiated benefits. : The International Prospective Register of Systematic Reviews (PROSPERO) does not accept scoping reviews, literature reviews, or mapping reviews.
复发性甲状舌管囊肿的管理一直面临挑战。本综述评估化学消融和手术再次干预作为复发治疗策略。然而，用于确定最佳方法和随访结果的比较研究有限。
本研究的目的是进行一项综述，收集文献证据，以分析和综合治疗复发性甲状舌管囊肿最安全、最有效的方法。
本研究旨在全面检索电子数据库，包括拉丁美洲和加勒比健康科学文献数据库（葡萄牙语：Literatura Latino-Americana e do Caribe em Ciências da Saúde，LILACS）、《美国医学会杂志》（JAMA）数据库、Scopus科学数据库、虚拟健康图书馆（葡萄牙语：Biblioteca Virtual em Saúde，BVS）和PubMed，以查找关于复发性甲状舌管囊肿的文章。所选文章包括复发性囊肿患者，涵盖2000年至2022年的出版物，描述临床和/或手术干预，并确保所分析方法的安全性和有效性。
本综述纳入了9项研究，涉及278例患者。其中，143例接受了手术干预，135例接受了化学消融（82例使用乙醇，53例使用OK-432）。
复发性甲状舌管囊肿的保守治疗是一个日益增长的趋势，尽管仍需进一步完善。这种方法具有潜在优势，包括复发率降低、手术时间缩短、成本效益高和恢复加快。然而，由于其已证实的疗效和广泛的认知度，手术干预仍然是首选的治疗方法。随着保守治疗获得确凿的益处，甲状舌管囊肿的预计治疗方法将会转变。
国际系统评价前瞻性注册库（PROSPERO）不接受范围综述、文献综述或映射综述。
